FIRPLUZA
Live / Registered — Registered (as of 13 Jan 2026)
What this means for you
Registered since 13 Jan 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Jan 2032: the §71 affidavit of use).
Record
- Serial number
- 79429330
- Registration number
- 8098110
- Mark type
- Word mark
- Filed
- 05 Jun 2025
- Published for opposition
- 25 Nov 2025
- Registered
- 13 Jan 2026
- Next maintenance filing
- §71 affidavit of use, due by 13 Jan 2032 (grace period to 13 Jul 2032)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for the prevention and treatment of lysosomal storage disorders, in particular Gaucher Disease, as well as of diseases and disorders affecting the central and peripheral nervous systems, including movement disorders, Parkinson's disease, and related parkinsonian conditions.
Owner
Prosecution history
- 12 Feb 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 13 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTICE OF PUBLICATION
- 29 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Oct 2025 — ASSIGNED TO EXAMINER
- 14 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 14 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Aug 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB